Aarey Drugs & Pharmaceuticals Limited

NSEI:AAREYDRUGS Stock Report

Market Cap: ₹1.6b

Aarey Drugs & Pharmaceuticals Management

Management criteria checks 4/4

Aarey Drugs & Pharmaceuticals' CEO is Mihir Ghatalia, appointed in Dec 2009, has a tenure of 14.92 years. total yearly compensation is ₹1.06M, comprised of 56.9% salary and 43.1% bonuses, including company stock and options. directly owns 16.49% of the company’s shares, worth ₹271.44M. The average tenure of the management team and the board of directors is 4.8 years and 4.6 years respectively.

Key information

Mihir Ghatalia

Chief executive officer

₹1.1m

Total compensation

CEO salary percentage56.9%
CEO tenure14.9yrs
CEO ownership16.5%
Management average tenure4.8yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Earnings Not Telling The Story For Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) After Shares Rise 46%

Aug 30
Earnings Not Telling The Story For Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) After Shares Rise 46%

Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) Shares May Have Run Too Fast Too Soon

Jul 16
Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) Shares May Have Run Too Fast Too Soon

Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Apr 15
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet

Mar 22
Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet

What Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) P/E Is Not Telling You

Dec 30
What Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) P/E Is Not Telling You

Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Shares Fly 25% But Investors Aren't Buying For Growth

Dec 29
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Shares Fly 25% But Investors Aren't Buying For Growth

Calculating The Fair Value Of Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

Aug 20
Calculating The Fair Value Of Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

CEO Compensation Analysis

How has Mihir Ghatalia's remuneration changed compared to Aarey Drugs & Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹60m

Jun 30 2024n/an/a

₹52m

Mar 31 2024₹1m₹600k

₹47m

Dec 31 2023n/an/a

₹29m

Sep 30 2023n/an/a

₹24m

Jun 30 2023n/an/a

₹37m

Mar 31 2023₹1m₹600k

₹38m

Dec 31 2022n/an/a

₹27m

Sep 30 2022n/an/a

₹41m

Jun 30 2022n/an/a

₹48m

Mar 31 2022₹2m₹600k

₹66m

Dec 31 2021n/an/a

₹87m

Sep 30 2021n/an/a

₹85m

Jun 30 2021n/an/a

₹77m

Mar 31 2021₹1m₹602k

₹65m

Dec 31 2020n/an/a

₹61m

Sep 30 2020n/an/a

₹58m

Jun 30 2020n/an/a

₹51m

Mar 31 2020₹1m₹600k

₹58m

Dec 31 2019n/an/a

₹55m

Sep 30 2019n/an/a

₹57m

Jun 30 2019n/an/a

₹65m

Mar 31 2019₹2m₹600k

₹65m

Dec 31 2018n/an/a

₹66m

Sep 30 2018n/an/a

₹69m

Jun 30 2018n/an/a

₹64m

Mar 31 2018₹300k₹300k

₹62m

Compensation vs Market: Mihir's total compensation ($USD12.49K) is below average for companies of similar size in the Indian market ($USD42.65K).

Compensation vs Earnings: Mihir's compensation has been consistent with company performance over the past year.

CEO

Mihir Ghatalia (41 yo)

14.9yrs

Tenure

₹1,055,262

Compensation

Mr. Mihir Rajesh Ghatalia, B.E., serves as an Executive Director at Worth Investment & Trading Company Limited. He has been the Managing Director at Aarey Drugs & Pharmaceuticals Ltd. since December 29, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Mihir Ghatalia
Chairman & MD14.9yrs₹1.06m16.49%
₹ 271.4m
Nimit Ghatalia
Executive Director4.3yrs₹758.07kno data
Mira Ghatalia
Chief Financial Officer3.8yrsno datano data
A. Kathawala
Chief Accountant26.8yrsno datano data
Preeti Rathi
Company Secretary & Compliance Officer4.8yrs₹429.23kno data

4.8yrs

Average Tenure

41yo

Average Age

Experienced Management: AAREYDRUGS's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mihir Ghatalia
Chairman & MD20.3yrs₹1.06m16.49%
₹ 271.4m
Nimit Ghatalia
Executive Director4.3yrs₹758.07kno data
Lalit Tulsiani
Non-Executive Independent Director4.8yrsno data0.0030%
₹ 48.7k
Bina Ghatalia
Non Independent Non-Executive Woman Director1.1yrsno data14.12%
₹ 232.4m
Chetan Kiritbhai Mehta
Non-Executive Independent Director16.4yrsno data1.06%
₹ 17.4m
Anil Mandal
Independent Non Executive Director4.3yrsno datano data

4.6yrs

Average Tenure

48.5yo

Average Age

Experienced Board: AAREYDRUGS's board of directors are considered experienced (4.6 years average tenure).